Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms

Patients with myeloid neoplasms who relapsed after allogenic hematopoietic stem cell transplant (HSCT) have poor prognosis. Monitoring of chimerism and specific molecular markers as a surrogate measure of relapse is not always helpful; therefore, improved systems to detect early relapse are needed....

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Med
Autores principales: Aguirre-Ruiz, Paula, Ariceta, Beñat, Viguria, María Cruz, Zudaire, María Teresa, Blasco-Iturri, Zuriñe, Arnedo, Patricia, Aguilera-Diaz, Almudena, Jauregui, Axier, Mañú, Amagoia, Prosper, Felipe, Mateos, María Carmen, Fernández-Mercado, Marta, Larráyoz, María José, Redondo, Margarita, Calasanz, María José, Vázquez, Iria, Bandrés, Eva
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7760908/
https://ncbi.nlm.nih.gov/pubmed/33255857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9123818
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares